Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages 1-8

  Hara, Megumi ^a   Fukuoka, Mami ^b   Tashiro, Katsuya ^a   Ozaki, Iwata ^c   Ohfuji, Satoko ^d   Okada, Kenji ^e   Nakano, Takashi ^f   Fukushima, Wakaba ^d   Hirota, Yoshio ^d,g  

^a SAGA UNIVERSITY   (Japan)

^b Saga Ken Medical Centre Koseikan   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d Osaka Prefecture University   (Japan)

^e FUKUOKA DENTAL COLLEGE   (Japan)

^f KAWASAKI MEDICAL SCHOOL   (Japan)

^g Internal Medicine Medical Co LTA PS Clinic   (Japan)

Author keywords

Outbreak; Pertussis; Vaccine effectiveness

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE; TOXIN ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CLINICAL EVALUATION; COUGHING; DRUG EFFICACY; EPIDEMIC; FEMALE; HUMAN; INFECTION PREVENTION; JAPAN; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; RISK ASSESSMENT; TREATMENT OUTCOME; UNIVERSITY STUDENT; VACCINATION; ADOLESCENT; IMMUNOLOGY; INCIDENCE; PROCEDURES; SECONDARY IMMUNIZATION; STATISTICS AND NUMERICAL DATA; STUDENT; UNIVERSITY; WHOOPING COUGH; YOUNG ADULT;

ADOLESCENT; ADULT; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INCIDENCE; JAPAN; MALE; STUDENTS; TREATMENT OUTCOME; UNIVERSITIES; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

EID: 84923913824     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-0777-3     Document Type: Article

References (26)

1. Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis. 2011;11(7):557-70.
2. Cherry JD. The present and future control of pertussis. Clin Infect Dis. 2010;51(6):663-7.
3. Cherry JD. Epidemic pertussis in 2012-the resurgence of a vaccinepreventable disease. N Engl J Med. 2012;367(9):785-7.
4. Cherry JD. Why do pertussis vaccines fail? Pediatrics. 2012;129(5):968-70.
5. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24(5 Suppl):S58-61.
6. Clark TA. Changing pertussis epidemiology: everything old is new again. J Infect Dis. 2014;209(7):978-81.
7. Bechini A, Tiscione E, Boccalini S, Levi M, Bonanni P. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations. Vaccine. 2012;30(35):5179-90.
8. CDC. Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older -Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2012;61:468-70.
9. Han HJ, Kamachi K, Okada K, Toyoizumi-Ajisaka H, Sasaki Y, Arakawa Y. Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan. Vaccine. 2008;26(12):1530-4.
10. Kamano H, Mori T, Maeta H, Taminato T, Ishida T, Kishimoto N, et al. Analysis of Bordetella pertussis agglutinin titers during an outbreak of pertussis at a university in Japan. Jpn J Infect Dis. 2010;63(2):108-12.
11. Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Kurose K, Oka M. Outbreak of pertussis in a university laboratory. Intern Med. 2011;50(8):879-85.
12. Kamiya H, Otsuka N, Ando Y, Odaira F, Yoshino S, Kawano K, et al. Transmission of Bordetella holmesii during pertussis outbreak, Japan. Emerg Infect Dis. 2012;18(7):1166-9.
13. Otsuka N, Han HJ, Toyoizumi-Ajisaka H, Nakamura Y, Arakawa Y, Shibayama K, et al. Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PLoS One. 2012;7(2):e31985.
14. Saito T, Akamatsu T, Aoyama T, Iwai H, Gonda T, Murase Y, et al. [Efficacy of acellular pertussis vaccine] in Japanese. Kansenshogaku Zasshi. 1990;64(5):564-9.
15. Okada K, Ohashi Y, Matsuo F, Uno S, Soh M, Nishima S. Effectiveness of an acellular pertussis vaccine in Japanese children during a non-epidemic period: a matched case-control study. Epidemiol Infect. 2009;137(1):124-30.
16. Kamachi K, Toyoizumi-Ajisaka H, Toda K, Soeung SC, Sarath S, Nareth Y, et al. Development and evaluation of a loop-mediated isothermal amplification method for rapid diagnosis of Bordetella pertussis infection. J Clin Microbiol. 2006;44(5):1899-902.
17. Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System. Pertussis (Whooping Cough) (bordetella pertussis) 2014 case definition. 2014. Available from: http://wwwn.cdc.gov/nndss/script/ casedef.aspx?CondYrID=950&DatePub=1/1/2014. Accessed January 30, 2015.
18. Jefferson T, Rudin M, DiPietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine. 2003;21(17-18):2003-14.
19. Cherry JD, Tan T, Wirsing von Konig CH, Forsyth KD, Thisyakorn U, Greenberg D, et al. Clinical definitions of pertussis: summary of a global pertussis initiative roundtable meeting, February 2011. Clin Infect Dis. 2012;54(12):1756-64.
20. Berger F, Njamkepo E, Minaberry S, Mayet A, Haus-Cheymol R, Verret C, et al. Investigation on a pertussis outbreak in a military school: risk factors and approach to vaccine efficacy. Vaccine. 2010;28(32):5147-52.
21. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012;367(11):1012-9.
22. Wei SC, Tatti K, Cushing K, Rosen J, Brown K, Cassiday P, et al. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis. Clin Infect Dis. 2010;51(3):315-21.
23. Baxter R, Bartlett J, Rowhani-Rahbar A, Fireman B, Klein NP. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ. 2013;347:f4249.
24. Okada K, Komiya T, Yamamoto A, Takahashi M, Kamachi K, Nakano T, et al. Safe and effective booster immunization using DTaP in teenagers. Vaccine. 2010;28(48):7626-33.
25. Hara M, Okada K, Yamaguchi Y, Uno S, Otsuka Y, Shimanoe C, et al. Immunogenicity and safety after booster vaccination of diphtheria, tetanus, and acellular pertussis in young adults: an open randomized controlled trial in Japan. Clin Vaccine Immunol. 2013;20(12):1799-804.
26. Ward JI, Cherry JD, Chang SJ, Partridge S, Lee H, Treanor J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med. 2005;353(15):1555-63.